Dosed is a feature documentary that has the power to help the 300 million people in the world suffering from illnesses like anxiety and depression, as well as the 1.3 billion people struggling with addictions of all kinds. Please get involved on social media @DoseMovie on instagram, facebook, twitter. Let’s get educated on this important cause and please donate to the film so we can make sure it ...
Continue Reading →Amanda Feilding: From Taboo to Treatment: The Coming of Age of Psychedelic Medicine
Learn more and donate: http://www.maps.org/
Amanda Feilding: From Taboo to Treatment – The Evolution of Psychedelic Medicine
2017 Psychedelic Science Conference
A six-day global gathering of the international scientific community in ...
The Action of Ibogaine
Ibogaine is the progressive process to help detox from drugs and stay off. Here we discuss the basics behind ibogaine’s mechanism of action and how it effects the brain during opiate detox. It is important to note that while Ibogaine is known as a tried and true detox for opiate users, it is also very effective for most other substance dependencies, problematic behaviors, and thought patterns. ...
Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico – Thomas Kingsley Brown
http://psychedelicscience.org
Help us caption and translate this video on Amara.org: http://www.amara.org/en/videos/ypBoaytF37qb/info/
Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico
Thomas Kingsley Brown, PhD
This presentation is an overview of the MAPS-funded study of long-term outcomes for ibogaine-assisted treatment of opiate dependence for patients at two clinics in Baja California, Mexico. Beginning in September of 2010, the study enrolled thirty US residents seeking ibogaine treatment for opiate dependence at the ...
Continue Reading →Notes on Progress in the New Zealand Ibogaine Study – Geoff Noller
http://psychedelicscience.org
Help us caption and translate this video on Amara.org: http://www.amara.org/en/videos/w5HzSJBjBSdf/info/
Notes on Progress in the New Zealand Ibogaine Study
Geoff Noller, PhD
This presentation reports on the first year of progress in the New Zealand observational study of ibogaine treatment outcomes for opioid-dependent persons. Current participants’ data are reviewed and the implications of New Zealand’s ibogaine legislation for research and treatment are discussed.
Dr. Geoff Noller has a background in social ...
Continue Reading →